Thymosin Alpha-1 60mg — Vial Spec, Reconstitution Math & COA

Thymosin Alpha-1 60mg Overview & Catalog Availability

Thymosin Alpha-1 (Tα1) is an acetylated 28-amino acid synthetic peptide corresponding to the naturally occurring sequence originating from thymic tissue. In high-yield laboratory settings, a 60mg format is primarily utilized by research institutions executing extensive serial dilutions, cell culture assays, or multi-target comparative studies requiring consistent lot uniformity across large sample sizes.

Please note: PX1 Research supplies standard research-grade compounds including our highly requested Thymosin Alpha-1 5mg vial format. While the 60mg mass configuration is typically reserved for specialized high-volume research contracts or custom analytical batches, understanding the reconstitution logistics and solubility dynamics of high-mass vials is critical for experimental accuracy. Researchers seeking standard working quantities or exploring our full catalog of research compounds can browse the complete PX1 Research peptide library.

Molecular Structure and Biochemical Characteristics

Thymosin Alpha-1 possesses the chemical formula C129H215N33O45 and a molecular weight of approximately 3108.5 Da. The peptide sequence consists of Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH. Its N-terminal acetylation provides enzymatic resistance against specific exopeptidases in aqueous media, maintaining structural integrity during extended benchtop exposure.

In cell-free and cell-culture research models, Thymosin Alpha-1 is studied for its interactions with pattern recognition receptors, specifically Toll-like receptor 4 (TLR4) and Toll-like receptor 3 (TLR3) signaling cascades. Preclinical studies suggest that Tα1 modulates downstream nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, providing a structural framework for investigating cell-mediated signaling, cytokine expression, and immune cell maturation in vitro.

High-Yield Reconstitution Mathematics (60mg Lyophilized Mass)

Reconstituting a 60mg cake requires careful diluent volume planning to prevent concentration saturation and ensure precise volumetric measurement. Depending on the assay requirements, researchers must calculate working stock concentrations (mg/mL and µg/µL) accurately before diluent introduction.

The mathematical relationship for concentration ($C$) given mass ($m$) and volume ($V$) is defined as $C = m / V$. Below are standard reconstitution outcomes for a 60mg Thymosin Alpha-1 vial:

• Reconstitution with 1.0 mL Diluent: Yields a concentration of 60.0 mg/mL (60.0 µg/µL). This hyper-concentrated stock is suitable for master aliquots but requires gentle, patient solvation due to increased solution viscosity. • Reconstitution with 2.0 mL Diluent: Yields a concentration of 30.0 mg/mL (30.0 µg/µL). This provides a balance between stock volume and concentration density for automated liquid handling systems. • Reconstitution with 3.0 mL Diluent: Yields a concentration of 20.0 mg/mL (20.0 µg/µL). A standard operational concentration for multi-well plate dispensing. • Reconstitution with 6.0 mL Diluent (or splitting into dual 3.0 mL vectors): Yields a concentration of 10.0 mg/mL (10.0 µg/µL), simplifying serial mathematical dilutions down to nanomolar working concentrations.

To quickly recalculate custom working volumes or verify concentration yields for custom bench setups, researchers should utilize the interactive PX1 reconstitution calculator.

Diluent Selection & Aliquoting Strategy for Large-Mass Vials

When handling high-mass vials such as a 60mg format, selecting the correct diluent is paramount for long-term stability. The primary diluent options include Bacteriostatic Water (0.9% benzyl alcohol preserved), Sterile Water for Injection (SWFI), and Sterile 0.9% Sodium Chloride (Normal Saline). For long-term stock preservation stored at 4°C, 0.9% benzyl alcohol-preserved water prevents microbial contamination over multiple syringe draws.

Repeated freeze-thaw cycles significantly degrade peptide integrity through ice crystal formation and shear mechanical stress on the peptide backbone. Therefore, once the 60mg lyophilized cake is fully reconstituted, the solution should be immediately aliquoted into single-use microcentrifuge tubes (e.g., 100 µL to 500 µL working volumes) using low-protein-binding polypropylene vessels. Aliquots designated for future testing should be stored at -20°C or -80°C to preserve peptide structure over multi-month assay timelines.

Analytical Verification: Lot-Matched COA, HPLC, and MS

High-yield peptide orders demand strict analytical confirmation to guarantee that batch consistency is maintained across entire lyophilization runs. Every batch of Thymosin Alpha-1 distributed by PX1 Research undergoes rigorous testing in an ISO 17025-accredited laboratory setting.

Analytical verification relies on High-Performance Liquid Chromatography (HPLC) to establish peptide purity (ensuring a threshold of ≥98.0%) and Mass Spectrometry (MS) to verify molecular identity against theoretical mass limits. Furthermore, because bacterial endotoxins can confound cell culture assays and receptor-binding data, routine Chromogenic LAL (Limulus Amebocyte Lysate) testing is performed to confirm endotoxin levels remain strictly below <0.01 EU/mg. Investigators can inspect lot-matched documentation prior to testing by accessing the official PX1 certificate of analysis portal.

Comparative Analysis: Immunomodulatory & Regenerative Research Peptides

In comparative preclinical protocols, Thymosin Alpha-1 is frequently evaluated alongside other thymic-derived signaling molecules, extracellular matrix fragments, and synthetic peptides. Understanding structural distinctions between these research compounds assists investigators in selecting the correct controls and active agents.

For instance, while Thymosin Alpha-1 primarily targets TLR-mediated immune signaling pathways, Thymosin Beta-4 operates through actin-sequestering mechanisms via its G-actin binding domain, mediating cell migration and tissue repair models. Similarly, researchers investigating broad antimicrobial or innate signaling mechanisms often compare Tα1 alongside synthetic host-defense peptides like LL-37 or tissue-remodeling agents such as GHK-Cu. Evaluating these distinct molecular pathways ensures accurate assay design across comparative cellular studies.

Choosing the Appropriate Format: 5mg vs. 60mg Bulk Quantities

Selecting between a standard format—such as the Thymosin Alpha-1 5mg vial—and a bulk 60mg unit depends on specific protocol parameters, assay duration, and reconstituting logistics:

• Standard 5mg Vials: Ideal for short-term assays, pilot exploratory runs, and single-plate experiments. Standard sizes minimize the risk of peptide degradation from prolonged storage after reconstitution and reduce potential batch loss due to unexpected laboratory contamination. • High-Yield 60mg Formats: Best suited for high-throughput screening, multi-center research projects, or automated robotic pipetting arrays where batch uniformity across thousands of microplate wells is strictly mandatory.

Laboratories planning large-scale research projects or requiring specialized volume fulfillments can review procurement options directly through the PX1 wholesale peptide program or explore background mechanics on our peptide research hub.

Storage, Handling, and Physicochemical Stability Guidelines

Lyophilized Thymosin Alpha-1 is highly stable when stored under controlled environmental conditions. Upon receipt, lyophilized vials should be kept in a desiccated freezer environment at -20°C or -80°C, protected from light exposure. Under these conditions, the dry peptide powder maintains structural purity for up to 24 months.

Following reconstitution, liquid stocks must be handled under aseptic conditions inside a laminar flow hood. Avoid aggressive vortexing or rapid agitation, as mechanical stress can induce aggregation or peptide denaturation. Gentle inversion or passive capillary wetting is recommended during initial reconstitution. Reconstituted aqueous solutions stored at 2°C to 8°C should be utilized within 14 to 21 days (if preserved with benzyl alcohol), while non-preserved aqueous solutions should be aliquoted and frozen immediately.